Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Stephanie Goletz
Introduction
Stephanie Goletz is a prominent inventor based in Lübeck, Germany. She has made significant strides in the field of medical diagnostics, particularly in the diagnosis of blistering autoimmune diseases. Her work has the potential to improve the lives of many patients suffering from these conditions.
Latest Patents
Stephanie Goletz holds a patent for the "Diagnosis of blistering autoimmune disease." This innovative patent describes a polypeptide that contains laminin beta-4, along with a carrier that includes this polypeptide. The patent also details an antibody, preferably an autoantibody, that targets laminin beta-4. Furthermore, it outlines the use of the polypeptide, carrier, or autoantibody for diagnosing the disease, as well as a method for detecting an autoantibody against laminin beta-4 in a sample.
Career Highlights
Stephanie is currently employed at Euroimmun Medizinische Labordiagnostika AG, a company known for its advancements in medical laboratory diagnostics. Her role at Euroimmun allows her to contribute to innovative solutions in the healthcare sector.
Collaborations
Throughout her career, Stephanie has collaborated with notable colleagues, including Christian Probst and Christiane Radzimski. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical technologies.
Conclusion
Stephanie Goletz's contributions to the field of medical diagnostics exemplify the impact of innovation in healthcare. Her patent on diagnosing blistering autoimmune diseases showcases her dedication to improving patient outcomes.